Comparative pharmacology of newer progestogens

H Kuhl - Drugs, 1996 - Springer
The newer progestogens desogestrel, norgestimate, gestodene, dienogest and nomegestrol
share the common property of having weak or no androgenic effects, but there is great …

Pharmacokinetics of oestrogens and progestogens

H Kuhl - Maturitas, 1990 - Elsevier
There are large inter-and intra-individual variations in the serum concentrations of natural
and synthetic sex steroids irrespective of the route of administration. Oral ingestion of …

5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as Potent, Orally Active, Nonsteroidal Progesterone Receptor Agonists:  The Effect of D-Ring Substituents

JP Edwards, SJ West, KB Marschke… - Journal of medicinal …, 1998 - ACS Publications
Several 5-(4-chlorophenyl)-1, 2-dihydro-5 H-chromeno [3, 4-f] quinolines were prepared to
determine the effects of substitution at C (8) and C (9) on the progestational activity of this …

General overview of mineralocorticoid hormone action

MK Agarwal, M Mirshahi - Pharmacology & therapeutics, 1999 - Elsevier
The adrenal cortex elaborates two major groups of steroids that have been arbitrarily
classified as glucocorticoids and mineralocorticoids, despite the fact that carbohydrate …

Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism

WH Catherino, MH Jeng, VC Jordan - British journal of cancer, 1993 - nature.com
There is great concern over the long-term influence of oral contraceptives on the
development of breast cancer in women. Oestrogens are known to stimulate the growth of …

Gestodene: a review of its pharmacology, efficacy and tolerability in combined contraceptive preparations

MI Wilde, JA Balfour - Drugs, 1995 - Springer
The newer progestogens gestodene, desogestrel and norgestimate were developed in an
attempt to produce agents with more selective progestational activity that would improve …

Interplay between thermodynamics and kinetics on polymorphic appearance in the solution crystallization of an enantiotropic system, gestodene

L Zhu, L Wang, Z Sha, Y Wang, L Yang… - Crystal Growth & …, 2017 - ACS Publications
The development of rational pharmaceutical polymorph control systems from crystallization
requires the experimental manipulation of both thermodynamic and kinetic factors. Herein …

Dihydrospirorenone (ZK30595): A novel synthetic progestagen-characterization of binding to different receptor proteins

K Pollow, M Juchem, W Elger, N Jacobi, G Hoffmann… - Contraception, 1992 - Elsevier
Abstract Dihydrospirorenone (6β, 7β, 15β, 16β-dimethylen-3-oxo-17a-pregn-4-en-21, 17-
carbolacton) is a new type of progestin with no other agonistic activities, in particular no …

Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays

U Fuhrmann, EP Slater, KH Fritzemeier - Contraception, 1995 - Elsevier
Gestodene is a novel progestin used in oral contracepttives with an increased separation of
progestogenic versus androgenic activity and a distinct antimineralocorticoid activity. This …

Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy

GL Hammond, T Rabe, JD Wagner - American Journal of Obstetrics & …, 2001 - ajog.org
Progestins used in oral contraceptive formulations available in the United States include
norgestimate, desogestrel, norethindrone, norethindrone acetate, and levonorgestrel …